Global Bio-chem Technology Group Co (HKSE:00809) Total Current Liabilities: HK$4,568 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00809 Global Bio-chem Technology Group Co Ltd HKSE:00809
33 GF Score
Price HK$0.40
! 5 Warning Signs
View Full Analysis

What is Global Bio-chem Technology Group Co Total Current Liabilities?

Global Bio-chem Technology Group Co HKSE:00809 33 Total Current Liabilities is HK$4,568 Mil as of Dec. 2025. GuruFocus rates HKSE:00809 with a GF Score™ of 33/100. The stock has 5 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Global Bio-chem Technology Group Co's total current liabilities for the quarter that ended in Dec. 2025 was HK$4,568


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Global Bio-chem Technology Group Co Total Current Liabilities Related Terms


Global Bio-chem Technology Group Co Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Global Bio-chem Technology Group Co's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Bio-chem Technology Group Co Total Current Liabilities Chart

Global Bio-chem Technology Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,035.68 13,506.00 8,395.60 6,486.15 4,568.04

Global Bio-chem Technology Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,395.60 6,670.74 6,486.15 6,328.24 4,568.04
HKSE:00809
33GF Score
Global Bio-chem Technology Group Co Ltd HKSE:00809
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Bio-chem Technology Group Co Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Global Bio-chem Technology Group Co's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1896.081+1233.393
+Other Current Liabilities+Current Deferred Liabilities
=1438.563+0
=4,568

Global Bio-chem Technology Group Co's Total Current Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=1896.081+1233.393
+Other Current Liabilities+Current Deferred Liabilities
=1438.563+0
=4,568

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of HK$4,568 Mil mean?
Global Bio-chem Technology Group Co (HKSE:00809) has a Total Current Liabilities of HK$4,568 Mil as of Dec. 2025. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Global Bio-chem Technology Group Co and its competitors.
Is Global Bio-chem Technology Group Co's Total Current Liabilities too high?
Global Bio-chem Technology Group Co's current Total Current Liabilities is HK$4,568 Mil. Overall, Global Bio-chem Technology Group Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Global Bio-chem Technology Group Co's Total Current Liabilities compare to KHC and GIS?
Global Bio-chem Technology Group Co's Total Current Liabilities of HK$4,568 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Consumer Packaged Goods company?
A good Total Current Liabilities depends on the Consumer Packaged Goods industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Global Bio-chem Technology Group Co and its competitors. Global Bio-chem Technology Group Co's current Total Current Liabilities is HK$4,568 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Bio-chem Technology Group Co stock overvalued right now?
Global Bio-chem Technology Group Co (HKSE:00809) has a current Total Current Liabilities of HK$4,568 Mil. The current Total Current Liabilities is HK$4,568 Mil. Global Bio-chem Technology Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Global Bio-chem Technology Group Co (HKSE:00809), the current Total Current Liabilities is HK$4,568 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Bio-chem Technology Group Co Business Description

Other Exchanges GBCMY:USAGLY:Germany
Address The Metropolis Tower, 10 Metropolis Drive, Unit 1206, 12th Floor, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG
Global Bio-chem Technology Group Co Ltd is engaged in the manufacture and sale of corn refined products and amino acids. The upstream corn refinery serves as a feedstock which breaks down corn kernels into corn starch, gluten meal, fibre and corn oil; and corn starch is further refined through a series of biochemical and/or chemical processes into a wide range of high value-added downstream products. Its segments include the upstream products segment; and the amino acids segment engages in the manufacture and sale of corn based biochemical products, including lysine and threonine. It derives the majority of the revenue from the amino acids segment. Geographically, it operates in The PRC, and Asia, the Americas and other regions.
33GF Score

Get the complete analysis for HKSE:00809

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.40
Price